EXMceuticals
Inc. (CSE: EXM)
(FSE: A2PAW2) (the “
Company” or
“
EXM”), a cultivator and producer of high-grade
cannabis extracted ingredients, for the pharmaceutical,
nutraceutical, therapeutical and cosmetic industries, is proud to
announce it has appointed Tripp Keber to the new role of Strategic
Advisor to the Board, effective immediately.
Mr. Keber will work closely with the Board of
Directors and existing executive management team to assist with the
future development of the company, bringing his significant
professional experience and connectivity totalling more than a
decade within the industrial cannabis, cannabinoid ingredients and
hemp industries.
Prior to joining EXM, he was the co-founder and
former CEO of Dixie Brands, Inc., a premium cannabis infused
product company. Dixie is known worldwide for its namesake
cannabis-infused beverages, Dixie Elixirs, Aceso and Therabis,
Dixie’s human and pet CBD wellness brand platforms respectively, as
well as hundreds of other cannabis products.
Mr. Keber has also served as a Director for
several cannabis industry organizations, including the National
Cannabis Industry Association, the Marijuana Policy Project, and
the National Association of Cannabis Businesses. He has also held
many senior and C-level positions in realty, communications and
other industries.
“Tripp is widely considered one of the most
prominent and well-known business leaders in the cannabis industry
and is recognized as an established branding expert in the medical
cannabis spaces. We are thrilled to announce he will be joining the
EXM team,” said Jonathan Summers, Chairman of EXM and
adds: “In his role as Strategic Advisor to the Board,
Tripp will assist with the development of EXM’s overall strategy,
help to grow our strong R&D activities, contribute to cultivate
relationships to enhance our market footprint, the development of
EXM’s products, as well as coordinate our go to market strategy.
Tripp already has a strong track record of actually delivering
results and should set EXM apart from the significant number of CPG
companies that are trying to build CBD businesses and wellness
brands; whereas.”
Tripp Keber added, “I have
spent the past two years evaluating companies across the globe that
have a unique and compelling business plan as well as strong
management team to back it up. EXM represents a ‘best of breed’
player in the industrial cannabinoid ingredients and hemp space and
I am incredibly honoured to have the privilege of advising the
Board.”
“Cultivators, processors and product
manufacturers will only survive in what is becoming a highly
competitive global market if they can scale operations
significantly as well as innovate. Cost efficiency and strong
R&D initiatives will be key. In my opinion EXM will not only
survive but could be a dominant player in the
market,” he went on to say.
ON BEHALF OF THE BOARD OF DIRECTORS OF
EXMCEUTICALS INC.Michel Passebon, Chief Executive Officer
and Director
FOR FURTHER INFORMATION
CONTACT
Investor
RelationsEmail: investors@exmceuticals.com
Media Enquiries:Email:
media@exmceuticals.com
Europe - Jane Glover: +44 (0) 203 757 4990
North America - Mélanie Guillemette:
+1 819 668 2734
FOR MORE UPDATES ON THE
COMPANY
Follow us on Twitter:
https://twitter.com/EXMceuticalsFollow us on LinkedIn:
https://www.linkedin.com/company/exmceuticals/
ABOUT EXMCEUTICALS
EXM’s activities are focused on the sustainable
cultivation of cannabis and hemp, and the production of high-grade
ingredients for the pharmaceutical, therapeutical, nutraceutical
and cosmetic industries. The Company proposes to sell the produced
ingredients to international markets.
Through its subsidiary, Prime Ranchers Limited,
EXM is able to cultivate and process cannabis in Uganda at an
industrial scale. The Uganda processing facilities are installed
and will produce and export pharmaceutical, therapeutical,
nutraceutical and cosmetic grade cannabis ingredients.
EXM owns a provisional license in Malawi
enabling the cultivation of 50Ha of Cannabis and is in the process
of obtaining a full license, in partnership with a large local agro
producer. Please see previous press releases for more detailed
information on EXM Malawi activities.
EXM, through its subsidiary and in-country
partner, holds the rights to a cannabis license in the Kuba
Kingdom, Mweka, Kasai Province, Democratic Republic of Congo, and
the rights to a land concession for the cultivation of cannabis and
hemp, and processing and export of high-grade cannabis extracted
ingredients.
EXM has also submitted applications and
undertaken negotiations with local governments and partners in
Ethiopia, Zambia, Eswatini and Burundi, in order to obtain licences
to permit the cultivation of cannabis and hemp, as well as the
processing, transformation and export of psychotropic and
non-psychotropic cannabinoid ingredients. In Ethiopia, EXM is in
its final stage of negotiation with the government for an
agro-industrial park, of 4,000 hectares (9,880 acres) encompassing
a free trade zone, for which EXM has already obtain land rights
over 2,000 hectares (4,940 acres) in the Amhara region.
FORWARD-LOOKING STATEMENTS
Certain statements and information included in
this press release that, to the extent they are not historical
fact, constitute forward-looking information or statements
(collectively, “forward-looking statements”) within the meaning of
applicable securities legislation. Forward-looking statements,
including those identified by the expressions “anticipate”,
“believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should”
and similar expressions to the extent they relate to the Company or
its management. Forward-looking statements are based on the
reasonable assumptions, estimates, analysis and opinions of
management made in light of its experience and its perception of
trends, current conditions and expected developments, as well as
other factors that management believes to be relevant and
reasonable in the circumstances at the date that such statements
are made, but which may prove to be incorrect.
Forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of the Company to
differ materially from any future results, performance or
achievements expressed or implied by the forward-looking
statements. Such risks and uncertainties include, among others, the
risk factors included in the Company’s Filing Statement dated as of
January 28, 2019, which is available under the Company’s SEDAR
profile at www.sedar.com. Accordingly, readers should not place
undue reliance on any such forward-looking statements. Further, any
forward-looking statement speaks only as of the date on which such
statement is made. New factors emerge from time to time, and it is
not possible for the Company's management to predict all of such
factors and to assess in advance the impact of each such factor on
the Company's business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
The Company does not undertake any obligation to update any
forward-looking statements to reflect information, events, results,
circumstances or otherwise after the date hereof or to reflect the
occurrence of unanticipated events, except as required by law
including securities laws. This news release does not constitute an
offer to sell or a solicitation of any offer to buy any securities
of the Company.
EXMceuticals (CSE:EXM)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
EXMceuticals (CSE:EXM)
Historical Stock Chart
Von Dez 2023 bis Dez 2024